Skip to content

Oroben Gel Oral

by Aboca S.P.A. Società Agricola Italy EUDAMED

Ref FROROGLX

EMDN V9017

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-ITM29499FROROGLX2P Basic UDI-DIDate2 Jul 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Oroben gel orale
Model / Reference
FROROGLX
Primary DI / UDI-DI
D-ITM29499FROROGLX2P
Basic UDI-DI
B-ITM29499FROROGLX2P
EMDN Code
V9017 Oral administration preparations not included in other classes
Device Class
Class IIa
Market of Registration
France

Manufacturer details

EUDAMED SRN
IT-MF-000029499

Other devices from Aboca S.P.A. Società Agricola

See all devices from Aboca S.P.A. Società Agricola →

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 453f56be-41a0-4a30-a39d-aba24c94f699 61 fields · synced 24 Oct 2026